[Chonnam National University_Medical School_Jungjun Min]

2018년 8월 8일 업데이트됨

첨부파일 : CHIP_Lab Survey_Min_IndieBio.pdf


Project Leader : Jung-Jun Min

Organization : Chonnam National University Medical School


- Research Sector : Attenuated Salmonella-based cancer therapy

- Research Goal : To develop a strategy for targeted cancer immunotherapy using an engineered avirulent S. typhimurium strain secreting FlaB (Toll-like receptor 5 ligand from Vibrio vulnificus flagellin B), which would enhance host immune activation at the desired time and location.

- Therapeutic Area : Solid cancers including colon cancer, melanoma, potentially effective with other types of solid cancer such as hepatocellular carcinoma, breast, lung and pancreatic cancers.

- Stage of Research : Preclinical studies with numerous cancer models in mice.

This strategy has been worked well with both subcutaneous murine colon cancer in immunocompetent mice and orthotopic human colon cancer in nude mice.

  • Facebook Social Icon

상호 : CHIP KAIST  |  대표 : 신성철
사업자 등록번호 : 314-82-01980  |  개인정보관리책임자 : CHIP KAIST
KAIST 371-1 Guseong-dong, Yuseong-gu, Daejeon, South Korea
PHONE : 042-350-4951 | EMAIL : chipkaist2016@gmail.com